Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 14, 2014; 20(6): 1602-1607
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1602
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1602
Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis
Jian-Bo Zhao, Chao Feng, Xiao-Feng He, Yan-Hao Li, Yong Chen, Department of Interventional Radiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China
Qiao-Hua Zhu, Department of Interventional Radiology, People’s Hospital, Southern Medical University, Shunde 528000, Guangdong Province, China
Author contributions: Zhao JB, Li YH and Chen Y designed the study; Zhao JB, Li YH, Chen Y and He XF performed the study; Feng C provided new reagents or analytic tools and analyzed the data; Zhao JB and Zhu QH wrote the paper.
Supported by Science and Technology Planning Project of Guangdong Province, China, No. 2012B010200027; The Key Technologies RD Program of Guangzhou, China; The Presidential Foundation of the Nanfang Hospital, Southern Medical University, Guangzhou, China, No. 2011B006
Correspondence to: Yong Chen, MD, Department of Interventional Radiology, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou South Avenue, Guangzhou 510515, Guangdong Pronvince, China. cheny102@163.com
Telephone: +86-20-61642084 Fax: +86-20-61648365
Received: September 23, 2013
Revised: November 13, 2013
Accepted: December 12, 2013
Published online: February 14, 2014
Processing time: 147 Days and 12.7 Hours
Revised: November 13, 2013
Accepted: December 12, 2013
Published online: February 14, 2014
Processing time: 147 Days and 12.7 Hours
Core Tip
Core tip: Tumor thrombus invasion of portal veins is very common in advanced hepatocellular carcinoma patients, especially in the patients presenting with upper gastrointestinal hemorrhage. Transjugular intrahepatic portosystemic shunt (TIPS) with bare stents has been attempted to treat those patients. We choose Fluency stent (Bard Inc, Germany) in this study, and our primary experience showed that the efficacy of TIPS with covered stents is favorable for treatment of complications related to portal hypertension due to tumor thrombus invasion in the main portal vein. Significant improvement of symptoms was observed in all the patients. The patency rate was 100%.